ALKS vs ROL · P/E 14, rev $1.56B vs P/E 41, rev $3.39B
Alkermes Plc (ALKS) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ALKS and ROL stock pages for the full models.
Not investment advice.